These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 26484665

  • 21. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z, Hartman C, Livnat G, Shteinberg M, Elenberg Y.
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865
    [Abstract] [Full Text] [Related]

  • 22. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
    Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A.
    Aliment Pharmacol Ther; 2004 Oct 01; 20(7):813-9. PubMed ID: 15379842
    [Abstract] [Full Text] [Related]

  • 23. Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection.
    Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, Di Dio G, Lionetti E, David A, Arrigo T, Salpietro C, La Rosa M.
    Clin Microbiol Infect; 2015 Apr 01; 21(4):368.e1-9. PubMed ID: 25658530
    [Abstract] [Full Text] [Related]

  • 24. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
    Zippi M, Al Ansari N, Siliquini F, Severi C, Kagarmanova A, Maffia C, Parlanti S, Garbarino V, Maccioni F.
    Clin Ter; 2010 Apr 01; 161(2):e53-6. PubMed ID: 20499020
    [Abstract] [Full Text] [Related]

  • 25. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.
    White H, Pollard K, Etherington C, Clifton I, Morton AM, Owen D, Conway SP, Peckham DG.
    J Cyst Fibros; 2009 May 01; 8(3):179-85. PubMed ID: 19179122
    [Abstract] [Full Text] [Related]

  • 26. The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes.
    Mulrennan S, Baltic S, Aggarwal S, Wood J, Miranda A, Frost F, Kaye J, Thompson PJ.
    Sci Rep; 2015 Mar 10; 5():8931. PubMed ID: 25754382
    [Abstract] [Full Text] [Related]

  • 27. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A, Stremler N, Dubus JC, Gross G, Sarles J, Reynaud R.
    Arch Pediatr; 2009 Dec 10; 16(12):1540-6. PubMed ID: 19854630
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of malnutrition and obesity among cystic fibrosis patients.
    Panagopoulou P, Fotoulaki M, Nikolaou A, Nousia-Arvanitakis S.
    Pediatr Int; 2014 Feb 10; 56(1):89-94. PubMed ID: 24003895
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of malnutrition in cystic fibrosis, and its treatment.
    Pencharz PB, Durie PR.
    Clin Nutr; 2000 Dec 10; 19(6):387-94. PubMed ID: 11104588
    [Abstract] [Full Text] [Related]

  • 30. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
    Engelen MP, Com G, Deutz NE.
    Clin Nutr; 2014 Dec 10; 33(6):1117-21. PubMed ID: 24423745
    [Abstract] [Full Text] [Related]

  • 31. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD, Kapsner RK, Osberg I.
    Pediatr Pulmonol; 2005 Mar 10; 39(3):224-32. PubMed ID: 15635615
    [Abstract] [Full Text] [Related]

  • 32. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 10; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 33. Plasma zinc in adults with cystic fibrosis: correlations with clinical outcomes.
    Damphousse V, Mailhot M, Berthiaume Y, Rabasa-Lhoret R, Mailhot G.
    J Trace Elem Med Biol; 2014 Jan 10; 28(1):60-4. PubMed ID: 24268877
    [Abstract] [Full Text] [Related]

  • 34. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
    Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H, ECFS Patient Registry Steering Group.
    Eur Respir J; 2014 Jan 10; 43(1):125-33. PubMed ID: 23598952
    [Abstract] [Full Text] [Related]

  • 35. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS, Jawad AF, FitzSimmons S, Stallings VA.
    J Pediatr; 2000 Sep 10; 137(3):374-80. PubMed ID: 10969263
    [Abstract] [Full Text] [Related]

  • 36. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis.
    Reisinger KW, Van der Zee DC, Brouwers HA, Kramer BW, van Heurn LW, Buurman WA, Derikx JP.
    J Pediatr Surg; 2012 Sep 10; 47(9):1640-5. PubMed ID: 22974599
    [Abstract] [Full Text] [Related]

  • 37. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR.
    PLoS One; 2015 Sep 10; 10(2):e0116967. PubMed ID: 25658710
    [Abstract] [Full Text] [Related]

  • 38. Adolescent development and energy expenditure in females with cystic fibrosis.
    Stallings VA, Tomezsko JL, Schall JI, Mascarenhas MR, Stettler N, Scanlin TF, Zemel BS.
    Clin Nutr; 2005 Oct 10; 24(5):737-45. PubMed ID: 16182037
    [Abstract] [Full Text] [Related]

  • 39. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC, de Lima Marson FA, Ribeiro JD, Paschoal IA, Pereira MC, Ribeiro AF, Bertuzzo CS.
    Gene; 2014 May 01; 540(2):183-90. PubMed ID: 24583165
    [Abstract] [Full Text] [Related]

  • 40. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A.
    Ann Nutr Metab; 2007 May 01; 51(6):541-9. PubMed ID: 18227622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.